In vitro evaluation of neuraminidase inhibitors using the neuraminidase-dependent release assay of hemagglutinin-pseudotyped viruses
- 14 April 2008
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 79 (3) , 199-205
- https://doi.org/10.1016/j.antiviral.2008.03.002
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Lipid Raft Disruption by Cholesterol Depletion Enhances Influenza A Virus Budding from MDCK CellsJournal of Virology, 2007
- Effect of influenza vaccine status on winter mortality in Spanish community-dwelling elderly people during 2002–2005 influenza periodsVaccine, 2007
- How influenza’s neuraminidase promotes virulence and creates localized lung mucosa immunodeficiencyCellular & Molecular Biology Letters, 2007
- Antiviral agents active against influenza A virusesNature Reviews Drug Discovery, 2006
- Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccinationProceedings of the National Academy of Sciences, 2006
- Avian influenza: A pandemic waiting in the wings?Emergency Medicine Australasia, 2006
- Effect of Hemagglutinin Glycosylation on Influenza Virus Susceptibility to Neuraminidase InhibitorsJournal of Virology, 2005
- Specificity of neuraminidase activity from influenza viruses isolated in different hosts tested with novel substratesArchiv für die gesamte Virusforschung, 2004
- Characterization of Sialidase from an Influenza A (H3N2) Virus Strain: Kinetic Parameters and Substrate SpecificityIntervirology, 2003
- In Vitro Selection and Characterization of Influenza A (A/N9) Virus Variants Resistant to a Novel Neuraminidase Inhibitor, A-315675Journal of Virology, 2002